⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CORT News
Corcept Therapeutics Inc.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming Deadlines - CORT
prnewswire.com
CORT
CORT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Corcept Therapeutics Incorporated Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
CORT
Corcept Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Corcept Therapeutics Incorporated - CORT
globenewswire.com
CORT
CORT ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss
globenewswire.com
CORT
Pomerantz LLP Issues Reminder to Shareholders in Corcept Therapeutics Incorporated of Class Action Lawsuit – CORT
accessnewswire.com
CORT
Form 8-K
sec.gov
CORT
FDA Approves Corcept’s Selective Glucocorticoid Receptor Antagonist Lifyorli™ (relacorilant) Plus Nab-Paclitaxel for Treatment of Patients with Platinum-Resistant Ovarian Cancer
businesswire.com
CORT
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Corcept Therapeutics Incorporated(CORT) Shareholders
prnewswire.com
CORT
Pomerantz LLP Issues Reminder to Shareholders in Corcept Therapeutics Incorporated of Class Action Filing – CORT
accessnewswire.com
CORT
CORT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Corcept Therapeutics Incorporated Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
CORT